Pradaxa dabigatran etexilate regulatory update

The U.K.'s NICE asked for additional information on the cost-effectiveness of Pradaxa dabigatran from Boehringer before recommending the

Read the full 182 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE